Work

Abstract CT238: Treatment of frailty with fisetin (TROFFi) in postmenopausal breast cancer survivors: A phase II randomized double-blind placebo-controlled study

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct238

Authors: Jingran Ji, Marla D. Lipsyc-Sharf, Nikita V. Baclig, Yulia A. Zektser, Ali Al Saleem, Joseph D. Olivera, Kelly S. Synold, Lauren R. Zelman, Catherine M. Crespi, Lisa D. Yee, Mina S. Sedrak

Institutions: University of California, Los Angeles, City Of Hope National Medical Center

Language: English

Topic: Cancer survivorship and care

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409821649

Cites:

Cited by:

Related to: 10